| USD millions | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) | — | |
| Research & development | 7.2 | 4.5 | 17.4 | 48.9 | 55.1 | +12.5% | |
| Selling, general & administrative | 2.7 | 2.2 | 5.3 | 13.8 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 11.4 | 7.4 | 22.8 | 62.7 | 74.0 | +17.9% | |
| Operating income | (11.4) | (7.4) | (22.8) | (62.7) | (74.0) | −17.9% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.1 | 1.4 | 2.4 | 5.1 | — | — | |
| Other income / expense | (2.2) | 0.2 | 2.2 | 5.1 | — | — | |
| Pre-tax income | (13.6) | (7.2) | (20.6) | (57.6) | (69.9) | −21.4% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (13.6) | (7.2) | (20.6) | (57.6) | (69.9) | −21.4% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (0.63) | (0.34) | (0.95) | (2.64) | (3.21) | −21.5% | |
| EPS, diluted (per share) | (0.63) | (0.34) | (0.95) | (2.64) | (3.21) | −21.5% | |
| EBITDA | (10.8) | (6.6) | (22.7) | (57.6) | (73.0) | −26.9% | |
| Depreciation & amortization | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | +16.7% | |
| Weighted average shares (shares) | 21,384,377 | 21,384,377 | 21,695,920 | 21,815,353 | — | — | |
| Weighted average diluted shares (shares) | 21,384,377 | 21,384,377 | 21,695,920 | 21,815,353 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
